Serum omentin-1 level in patients with benign prostatic hyperplasia.

Haiqing HeShuiqing WuJun HaoLong WangKai AiXuan ZhuRan XuXiaokun ZhaoYinhuai WangZhaohui Zhong

Published in: BMC urology (2020)

Omentin-1 may suppress the development of BPH and Lower serum omentin-1 levels in BPH patients might associated with higher prostate volume and higher IL-8 and IL-18 expression levels in their prostatic cells.

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
end stage renal disease
newly diagnosed
induced apoptosis
poor prognosis
prognostic factors
prostate cancer
cell cycle arrest
peritoneal dialysis
signaling pathway
cell proliferation
patient reported
pi k akt